These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10627130)

  • 1. [PFTalpha, guardian of the sick?].
    Jacquemin-Sablon A
    Bull Cancer; 1999 Nov; 86(11):894-5. PubMed ID: 10627130
    [No Abstract]   [Full Text] [Related]  

  • 2. Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells.
    Kaji A; Zhang Y; Nomura M; Bode AM; Ma WY; She QB; Dong Z
    Mol Carcinog; 2003 Jul; 37(3):138-48. PubMed ID: 12884365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer research. A new way to combat therapy side effects.
    Ferber D
    Science; 1999 Sep; 285(5434):1651, 1653. PubMed ID: 10523177
    [No Abstract]   [Full Text] [Related]  

  • 4. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
    Komarov PG; Komarova EA; Kondratov RV; Christov-Tselkov K; Coon JS; Chernov MV; Gudkov AV
    Science; 1999 Sep; 285(5434):1733-7. PubMed ID: 10481009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 inhibitor pifithrin alpha can suppress heat shock and glucocorticoid signaling pathways.
    Komarova EA; Neznanov N; Komarov PG; Chernov MV; Wang K; Gudkov AV
    J Biol Chem; 2003 May; 278(18):15465-8. PubMed ID: 12637507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of high-fidelity double-strand break repair in mammalian chromosomes by pifithrin-alpha, a chemical inhibitor of p53.
    Lin Y; Waldman BC; Waldman AS
    DNA Repair (Amst); 2003 Jan; 2(1):1-11. PubMed ID: 12509264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha.
    Leker RR; Aharonowiz M; Greig NH; Ovadia H
    Exp Neurol; 2004 Jun; 187(2):478-86. PubMed ID: 15144874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical-mediated inactivation of p53 sensitizes U87MG glioma cells to BCNU and temozolomide.
    Xu GW; Mymryk JS; Cairncross JG
    Int J Cancer; 2005 Aug; 116(2):187-92. PubMed ID: 15800902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of p53: a new approach to overcome side effects of antitumor therapy.
    Komarova EA; Gudkov AV
    Biochemistry (Mosc); 2000 Jan; 65(1):41-8. PubMed ID: 10702639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pifithrin-alpha inhibits p53 signaling after interaction of the tumor suppressor protein with hsp90 and its nuclear translocation.
    Murphy PJ; Galigniana MD; Morishima Y; Harrell JM; Kwok RP; Ljungman M; Pratt WB
    J Biol Chem; 2004 Jul; 279(29):30195-201. PubMed ID: 15145929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide.
    Culmsee C; Zhu X; Yu QS; Chan SL; Camandola S; Guo Z; Greig NH; Mattson MP
    J Neurochem; 2001 Apr; 77(1):220-8. PubMed ID: 11279278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A chemical inhibitor of p53 that protects mice from the side effects of cancer treatment].
    Stadler P; Grosu AL; Molls M
    Strahlenther Onkol; 2000 Feb; 176(2):98. PubMed ID: 10697660
    [No Abstract]   [Full Text] [Related]  

  • 13. Pifithrin-alpha suppresses p53 and protects cochlear and vestibular hair cells from cisplatin-induced apoptosis.
    Zhang M; Liu W; Ding D; Salvi R
    Neuroscience; 2003; 120(1):191-205. PubMed ID: 12849752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of p53, p21 and Bax by pifithrin-alpha does not affect UV induced apoptotic response in CS-B cells.
    Proietti De Santis L; Balajee AS; Lorenti Garcia C; Pepe G; Worboys AM; Palitti F
    DNA Repair (Amst); 2003 Aug; 2(8):891-900. PubMed ID: 12893085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pifithrin-α enhancing anticancer effect of topotecan on p53-expressing cancer cells.
    Guo J; Tang Q; Wang Q; Sun W; Pu Z; Wang J; Bao Y
    Eur J Pharm Sci; 2019 Feb; 128():61-72. PubMed ID: 30472223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.
    Burdelya LG; Komarova EA; Hill JE; Browder T; Tararova ND; Mavrakis L; DiCorleto PE; Folkman J; Gudkov AV
    Cancer Res; 2006 Oct; 66(19):9356-61. PubMed ID: 17018587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolinium salt as a potent inhibitor of lymphocyte apoptosis.
    Barchéchath SD; Tawatao RI; Corr M; Carson DA; Cottam HB
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1785-8. PubMed ID: 15780606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective therapeutic applications of p53 inhibitors.
    Gudkov AV; Komarova EA
    Biochem Biophys Res Commun; 2005 Jun; 331(3):726-36. PubMed ID: 15865929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism.
    Pietrancosta N; Moumen A; Dono R; Lingor P; Planchamp V; Lamballe F; Bähr M; Kraus JL; Maina F
    J Med Chem; 2006 Jun; 49(12):3645-52. PubMed ID: 16759106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to apoptosis in prostate cancer cells.
    Howell SB
    Mol Urol; 2000; 4(3):225-9;discussion 231. PubMed ID: 11062378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.